Brett Cucchiara, MD
Vascular Neurology · Philadelphia, PANPI 1942241674
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $2,287 of the $2,383 with a category attached, or 96.0%. Bayer accounts for 96.0% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2019 at $1,753 and has fallen 65.2% since, to $611 in 2024.
Across 6 payments — averaging $397.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$2K
- Philips North America LLC$43
- Biogen$37
- Medtronic$16
Across 32 payments — averaging $32,840 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- E.r. Squibb & Sons, L.L.C.$659K
- Imperative Care, Inc$327K
- Janssen Research & Development, LLC$44K
- Novo Nordisk AS$21K
What the payments were for
- Consulting fees$2,28796%
- Food & beverage$964%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 2 | $2,287 |
| Philips North America LLC | 2 | $43 |
| Biogen | 1 | $37 |
| Medtronic | 1 | $16 |
How this compares
$2,383 in reported general payments places this provider in the 80th percentile of 52 vascular neurology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 14 | $9,298 |
| ClopidogrelClopidogrel Bisulfate | 12 | $419 |
Paid to pharmacies, not to this prescriber.
Other vascular neurology in Philadelphia
- Scott KasnerPhiladelphia$210K
- Michael McGarveyPhiladelphia$15K
- Steven MessePhiladelphia$14K
- Donna GeorgePhiladelphia$4K
- Sydni ColePhiladelphia$408
- Paul NovelloPhiladelphia$122
- Christopher FavillaPhiladelphia$109
- Kelley HumbertPhiladelphia$85
- Qingyang YuanPhiladelphia$79
- Laura SteinPhiladelphia$64
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.